NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- WeRide (Nasdaq: WRD), the leading global commercial-stage company developing autonomous driving technologies from Level 2 to Level 4, announced that...
NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD), a global leader and a first mover in the autonomous driving industry, today announced that its...
NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- WeRide, the leading global commercial-stage company, was officially listed on the Nasdaq Global Select Market under the ticker symbol "WRD." Upon...
Qiming Venture Partners Celebrates WeRide's IPO on Nasdaq PR Newswire SHANGHAI, Oct. 25, 2024 SHANGHAI, Oct. 25, 2024 /PRNewswire/ -- On October 25th, 2024, Beijing Time, WeRide, a world-leading...
Qiming Venture Partners Celebrates WeRide's IPO on Nasdaq PR Newswire SHANGHAI, Oct. 25, 2024 SHANGHAI, Oct. 25, 2024 /PRNewswire/ -- On October 25th, 2024, Beijing Time, WeRide, a world-leading...
The World's First IPO of Universal Autonomous Driving Technology Company! WeRide Officially Listed on Nasdaq PR Newswire NEW YORK, Oct. 25, 2024 NEW YORK, Oct. 25, 2024 /PRNewswire/ -- WeRide...
NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD), a global leader and a first mover in the autonomous driving industry, today announced the...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales